Wonderful! Highly anticipated update on CMV definitions for trials as the field evolves. Highlights include updated refractory CMV and GI disease in SOT. A big collective effort by TAVI forum. Camille Nelson Kotton Dr Roy Chemaly genovefa papanicolaou NCIC

Want to know how to join our research team NCIC?Want to ask an in depth question or evaluate how well we are managing infections in ICH? #TID Thursday hear about our amazing research fellows with pharm background. All welcome! Courtney Ierano NCAS_Australia @vzzhu1 julianlindsay_

100% agree! So talented and experts in epidemiology, trials, data science, AI, implementation. Following your lead Jason Roberts!! NCIC

Infectious diseases got the guernsey for the first NEJM/Dr. Glaucomflecken TikTok. Very clever

Quantiferon mediated CMV assay as a marker for cell mediated immunity to decide the duration of CMV prophylaxis in high-risk organ transplant recipients appears to be of use in seropositive recipients in this very interesting paper by Solera et al. tinyurl.com/9kb85t49

Register now for our hybrid annual Symposium "Tackling Fungal infections" cancerandinfections.org/annual-ncic-sy… 10am Melbourne, Australia time Friday 1st Nov. Michelle Yong

My view and quote on Chandipura virus in "The Lancet " vector control, vaccine & surveillance thelancet.com/journals/lance… RahulDoc Swati Bhayana Fortis Healthcare The Lancet IDSA Tedros Adhanom Ghebreyesus Prashant Mehta Michelle Yong Michael Ison, MD MS Neil Stone Petra Heitkamp Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 NCDC

Please join ESGICH for our first session of our Webinar Series on September 24 at 12pm CET/8pm Melbourne/6am EST. This webinar will focus on Stewardship in ICHs. Chairs: Abby Douglas & Mark DeBoer Talks by: Jason Trubiano 🆔, Alessandra Mularoni & Dr. Milkulska escmid-org.zoom.us/webinar/regist…

Really looking forward to co-chairing this important and stimulating session! Much to do in the AMS space in ICH, we will hear from experts about recent research and new approaches. escmid-org.zoom.us/webinar/regist…. #TxID

This is well worth a read, I've done so twice so far, if interested in Bayesian statistics for research and clinical trials. Very clearly written. thelancet.com/journals/lance…

Poster presentations in session… presenting influenza-specific B & T cell analyses in pts w/ haematological malignancy - T cell responses preserved & less dependent on underlying disease and treatment regimen received. NCIC Kedzierska Lab Infectious Diseases at Austin Health Ben Teh Options2024

【Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections】Curr Opin Infect Dis, Oct 5 2024 👉Congrats, Erika Erika Kampouri Fred Hutch Cancer Center Université de Lausanne🎉 👉Comprehensive review on the epidemiology of viral infections and critical approaches to

We are so fortunate to host #TxID and infx prevention expert Dr. Priya Garg joining us from Melbourne 🇦🇺 ⁦⁩- discussing maribavir use with our award-winning ID fellow Chelsea Morinishi ⁦David Geffen School of Medicine at UCLA⁩ NCIC ⁦Peter Mac Cancer Centre⁩ ⁦@UCLA_ID⁩ ⁦TTS⁩

Great to be here with Dr Roy Chemaly ban hock - we talk about challenges and controversies in CMV at APBMT. ICHS-Global NCIC

Thanks @GermHunterMD this is an important paper. Please read. EORTC/MSGERC criteria on host factors, repeat molecular testing , excluded these patients from meeting IA definitions - they have similar high mortality NCIC monica slavin

【The heterogeneous syndrome of non-infectious causes of persistent fever in neutropenic patients with hematologic malignancy: another opportunity for stewardship?】Clinical Infectious Diseases Oct 14, 2024 👉Useful table for the differential diagnosis of persistent fever in neutropenic fever by

Secondary antiviral prophylaxis after treatment of CMV infection and disease: systematic review and metaanalysis doi.org/10.1111/tid.14…

#ICHSglobal now had country ambassadors to disseminate information about #immunocompromised host information throughout the world. Welcome them!

fredhutch.org/content/www/en… via Fred Hutch Cancer Center With increasing infectious disease threats plus a growing population of people with weakened immune systems, we think the time is right to establish a national network dedicated to trials at this intersection.

Starting now NCIC Fungal Symposium with Prof Kontoyiannis speaking! A difficult case with proptosis with fungal elements. I know it’s Halloween in the US but having Dimitrios speak is a real treat ! 👻🎃NCIC @PergamIC julianlindsay_ ICHS-Global monica slavin